| molecular function |
|---|
| | GO:0042289 | | MHC class II protein binding | | Interacting selectively and non-covalently with major histocompatibility complex class II molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation. |
| | GO:0042658 | | MHC class II protein binding, via antigen binding groove | | Interacting selectively and non-covalently with the antigen binding groove of major histocompatibility complex class II molecules. |
| | GO:0023026 | | MHC class II protein complex binding | | Interacting selectively and non-covalently with the class II major histocompatibility complex. |
| | GO:0001540 | | amyloid-beta binding | | Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor. |
| | GO:0019955 | | cytokine binding | | Interacting selectively and non-covalently with a cytokine, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity. |
| | GO:0004896 | | cytokine receptor activity | | Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| | GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| | GO:0035718 | | macrophage migration inhibitory factor binding | | Interacting selectively and non-covalently with the cytokine, macrophage migration inhibitory factor. |
| | GO:0050998 | | nitric-oxide synthase binding | | Interacting selectively and non-covalently with the enzyme nitric-oxide synthase. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0044183 | | protein binding involved in protein folding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules) that contributes to the process of protein folding. |
| biological process |
|---|
| | GO:0045058 | | T cell selection | | The process in which T cells that express T cell receptors that are restricted by self MHC protein complexes and tolerant to self antigens are selected for further maturation. |
| | GO:0000187 | | activation of MAPK activity | | The initiation of the activity of the inactive enzyme MAP kinase (MAPK). |
| | GO:0002250 | | adaptive immune response | | An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory). |
| | GO:0019882 | | antigen processing and presentation | | The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex. |
| | GO:0019883 | | antigen processing and presentation of endogenous antigen | | The process in which an antigen-presenting cell expresses antigen (peptide or lipid) of endogenous origin on its cell surface in association with an MHC protein complex. |
| | GO:0019886 | | antigen processing and presentation of exogenous peptide antigen via MHC class II | | The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein. |
| | GO:0008283 | | cell proliferation | | The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
| | GO:0051085 | | chaperone mediated protein folding requiring cofactor | | The process of assisting in the correct posttranslational noncovalent assembly of proteins, which is dependent on additional protein cofactors. This process occurs over one or several cycles of nucleotide hydrolysis-dependent binding and release. |
| | GO:0006952 | | defense response | | Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack. |
| | GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| | GO:0002376 | | immune system process | | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| | GO:0016064 | | immunoglobulin mediated immune response | | An immune response mediated by immunoglobulins, whether cell-bound or in solution. |
| | GO:0006886 | | intracellular protein transport | | The directed movement of proteins in a cell, including the movement of proteins between specific compartments or structures within a cell, such as organelles of a eukaryotic cell. |
| | GO:0050900 | | leukocyte migration | | The movement of a leukocyte within or between different tissues and organs of the body. |
| | GO:0035691 | | macrophage migration inhibitory factor signaling pathway | | A series of molecular signals initiated by the binding of macrophage migration inhibitory factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0043518 | | negative regulation of DNA damage response, signal transduction by p53 class mediator | | Any process that stops, prevents, or reduces the frequency, rate or extent of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage. |
| | GO:0045581 | | negative regulation of T cell differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of T cell differentiation. |
| | GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| | GO:1902166 | | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator. |
| | GO:0002906 | | negative regulation of mature B cell apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate, or extent of mature B cell apoptotic process. |
| | GO:0002792 | | negative regulation of peptide secretion | | Any process that stops, prevents, or reduces the frequency, rate, or extent of peptide secretion. |
| | GO:0045060 | | negative thymic T cell selection | | The process of elimination of immature T cells in the thymus which react strongly with self-antigens. |
| | GO:0030890 | | positive regulation of B cell proliferation | | Any process that activates or increases the rate or extent of B cell proliferation. |
| | GO:0070374 | | positive regulation of ERK1 and ERK2 cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| | GO:0045582 | | positive regulation of T cell differentiation | | Any process that activates or increases the frequency, rate or extent of T cell differentiation. |
| | GO:2000343 | | positive regulation of chemokine (C-X-C motif) ligand 2 production | | Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production. |
| | GO:0001961 | | positive regulation of cytokine-mediated signaling pathway | | Any process that activates or increases the frequency, rate or extent of a cytokine mediated signaling pathway. |
| | GO:0002606 | | positive regulation of dendritic cell antigen processing and presentation | | Any process that activates or increases the frequency, rate, or extent of dendritic cell antigen processing and presentation. |
| | GO:0048146 | | positive regulation of fibroblast proliferation | | Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
| | GO:0060907 | | positive regulation of macrophage cytokine production | | Any process that increases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. |
| | GO:0090023 | | positive regulation of neutrophil chemotaxis | | Any process that increases the frequency, rate, or extent of neutrophil chemotaxis. Neutrophil chemotaxis is the directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. |
| | GO:0050731 | | positive regulation of peptidyl-tyrosine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| | GO:0002830 | | positive regulation of type 2 immune response | | Any process that activates or increases the frequency, rate, or extent of a type 2 immune response. |
| | GO:0045059 | | positive thymic T cell selection | | The process of sparing immature T cells in the thymus which react with self-MHC protein complexes with low affinity levels from apoptotic death. |
| | GO:0001516 | | prostaglandin biosynthetic process | | The chemical reactions and pathways resulting in the formation of prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring. |
| | GO:0006461 | | protein complex assembly | | The aggregation, arrangement and bonding together of a set of components to form a protein complex. |
| | GO:0043030 | | regulation of macrophage activation | | Any process that modulates the frequency or rate of macrophage activation. |
| | GO:0007165 | | signal transduction | | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
| cellular component |
|---|
| | GO:0012507 | | ER to Golgi transport vesicle membrane | | The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi. |
| | GO:0005794 | | Golgi apparatus | | A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions. |
| | GO:0000139 | | Golgi membrane | | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
| | GO:0042613 | | MHC class II protein complex | | A transmembrane protein complex composed of an MHC class II alpha and MHC class II beta chain, and with or without a bound peptide or polysaccharide antigen. |
| | GO:0035693 | | NOS2-CD74 complex | | A protein complex comprising nitric oxide synthase 2 and CD74. This stable complex formation is thought to prevent CD74 degradation by caspases. |
| | GO:0009986 | | cell surface | | The external part of the cell wall and/or plasma membrane. |
| | GO:0030669 | | clathrin-coated endocytic vesicle membrane | | The lipid bilayer surrounding a clathrin-coated endocytic vesicle. |
| | GO:0030666 | | endocytic vesicle membrane | | The lipid bilayer surrounding an endocytic vesicle. |
| | GO:0005783 | | endoplasmic reticulum | | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
| | GO:0005789 | | endoplasmic reticulum membrane | | The lipid bilayer surrounding the endoplasmic reticulum. |
| | GO:0005768 | | endosome | | A vacuole to which materials ingested by endocytosis are delivered. |
| | GO:0009897 | | external side of plasma membrane | | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0071556 | | integral component of lumenal side of endoplasmic reticulum membrane | | The component of the endoplasmic reticulum membrane consisting of the gene products that penetrate only the lumenal side of the membrane. |
| | GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0005622 | | intracellular | | The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. |
| | GO:0005770 | | late endosome | | A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center. |
| | GO:0043202 | | lysosomal lumen | | The volume enclosed within the lysosomal membrane. |
| | GO:0005765 | | lysosomal membrane | | The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm. |
| | GO:0005764 | | lysosome | | A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions. |
| | GO:0035692 | | macrophage migration inhibitory factor receptor complex | | A protein complex that binds macrophage migration inhibitory factor. Comprises CD74 and CD44 cell surface proteins. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0005771 | | multivesicular body | | A type of endosome in which regions of the limiting endosomal membrane invaginate to form internal vesicles; membrane proteins that enter the internal vesicles are sequestered from the cytoplasm. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| | GO:0032588 | | trans-Golgi network membrane | | The lipid bilayer surrounding any of the compartments that make up the trans-Golgi network. |
| | GO:0030658 | | transport vesicle membrane | | The lipid bilayer surrounding a transport vesicle. |
| | GO:0005773 | | vacuole | | A closed structure, found only in eukaryotic cells, that is completely surrounded by unit membrane and contains liquid material. Cells contain one or several vacuoles, that may have different functions from each other. Vacuoles have a diverse array of functions. They can act as a storage organelle for nutrients or waste products, as a degradative compartment, as a cost-effective way of increasing cell size, and as a homeostatic regulator controlling both turgor pressure and pH of the cytosol. |
Description
